Delcath Systems, Inc.

DCTH Healthcare Medical Devices

Delcath Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $85.2 million, up 129.1% from fiscal 2024. In the quarter to June 2026, revenue grew 20.6%, EPS fell 12.5% and free cash flow fell 24.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

14.08 0.73 −4.93%
Market cap
$513.9M
P/E
1,408×
Fwd P/E
−17.8×
Dividend yield
—
F-score
7/9
Altman Z
13.26
Beneish M
−2.73
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

537.50 126.25 464.00 1,259.00
P/S ratio
4.91 4.24 3.70 4.74
P/FCF ratio
32.50 17.25 17.42 25.81
P/Operating CF
81.96 43.86 390.05 79.11
P/B ratio
3.41 3.25 2.97 3.73
EV/Sales
3.82 3.20 2.73 3.75
EV/EBITDA
63.15 0.00 0.00 0.00
EV/FCF
25.27 13.01 12.87 20.45
Current Ratio
15.06 10.92 11.24 9.83
Net Debt/EBITDA
115.62 35.94 45.89 (45.07)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
0.19% 0.79% 0.22% 0.08%
Free Cash Flow Yield
3.08% 5.80% 5.74% 3.87%
Free Cash Flow per Share
0.12 0.21 0.01 0.15
Book value per Share
3.16 3.10 3.13 3.38
Free Cash Flow
4.31 7.70 0.29 5.21
EV/EBIT
51.71 413.27 0.00 0.00
Other line items

Show all line items

Columns are period end dates